Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Bereczky Zsuzsanna, MD PhD, Speker Marianna, Al-Muhanna Marie, Balogh Gábor, Boda Zoltán, MD PhD DSc, Pfliegler György, MD PhD, Schlammadinger Ágota, MD PhD, Kerényi Adrienn, MD PhD, Csongor Kiss, MD PhD DSc

Blood (2019) 134 (Supplement_1): 2394.

https://doi.org/10.1182/blood-2019-125504

Published: 2019

Journal Articles

Prospective Controlled Monitoring of Hemlibra Prophylaxis Initiation in a Large Cohort of Hemophilia a Patients- Real World Data

Assaf Arie Barg, Tami Livnat, PhD, Tami Brutman-Barazani, Nurit Rosenberg, Ivan Budnik, MD PhD, Gili Kenet

Blood (2019) 134 (Supplement_1): 2397.

https://doi.org/10.1182/blood-2019-122010

Published: 2019

Journal Articles

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Donald M. Arnold, MD, Nancy Heddle, MSc, Richard Cook, Cyrus C. Hsia, MDBSc,FRCPC, Mark Blostein, MDFRCPC, Erin Jamula, MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc, Yulia Lin, MD, Jeannine Kassis, MD, Loree Larratt, MD FRCP(C), Sufia Amini, MD, Martin R. Schipperus, Wendy Lim, MD MSc, Prakash Vishnu, MD, Margaret Warner, FRCPC, Julie Carruthers, MLT, B.Com(Hon), Shannon J Lane, MPH, Na Li, PhD, John G. Kelton, MD

Blood (2019) 134 (Supplement_1): 896.

https://doi.org/10.1182/blood-2019-122609

Published: 2019

Journal Articles

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Atsushi Okamoto, MD, Kenta Yamamoto, Go Eguchi, Yoshitaka Kanai, Terufumi Yamaguchi, Yasuhiro Maeda, MD PhD

Blood (2018) 132 (Supplement 1): 5082.

https://doi.org/10.1182/blood-2018-99-115755

Published: 2018

Journal Articles

Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study

Guy Young, Ri Liesner, Robert F. Sidonio, Jr., Johannes Oldenburg, Victor Jimenez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Tiffany Chang, Marianne Uguen, Michelle Doral, Christophe Schmitt, Gallia G. Levy, Midori Shima, MD PhD, Maria Elisa Mancuso

Blood (2018) 132 (Supplement 1): 632.

https://doi.org/10.1182/blood-2018-99-118153

Published: 2018

Journal Articles

Bleeding Risk Using INR/aPTT Pre-Surgery: Systemtic Review (BRUISR) (BRUISR)

Larissa Liontos, MD PhD, Michael Fralick, MD, Avery Longmore, BSc, Lisa K. Hicks, MD MSc, Michelle Sholzberg, MDM, MSc, FRCPC

Blood (2017) 130 (Supplement 1): 4654.

https://doi.org/10.1182/blood.V130.Suppl_1.4654.4654

Published: 2017

Journal Articles

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Rebecca Kruse-Jarres, Michael U. Callaghan, Stacy E. Croteau, MD, Victor Jimenez-Yuste, Liane Khoo, Ri Liesner, Tadashi Matsushita, Michael Recht, Guy Young, Tiffany Chang, Christophe Dhalluin, Yunming Mu, Jin Xu, Jenny Devenport, Richard H. Ko, Paul Solari, Johannes Oldenburg

Blood (2017) 130 (Supplement 1): 89.

https://doi.org/10.1182/blood.V130.Suppl_1.89.89

Published: 2017

Journal Articles

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Aditi Khandelwal, MDM, Syed Mahamad, BSc candidate, Jerome M. Teitel, MD, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1418.

https://doi.org/10.1182/blood.V128.22.1418.1418

Published: 2016

Journal Articles

Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Davide Matino, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 1408.

https://doi.org/10.1182/blood.V128.22.1408.1408

Published: 2016

Journal Articles

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Lidia Cosentino, PhD, Paula D. James, MD, Michelle Sholzberg, MDM, MSc, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 2593.

https://doi.org/10.1182/blood.V128.22.2593.2593

Published: 2016

Journal Articles

Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review

Chatree Chai-Adisaksopha, MD, Thanawat Rattanathammethee, MD, Milana Drakulic, Davide Matino, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 3796.

https://doi.org/10.1182/blood.V128.22.3796.3796

Published: 2016

Journal Articles

Bridging Therapy with Sodium Bemiparin at Therapeutic-Dose: Experience in Our Hospital

Almudena Garcia Ruiz, DOCTOR, Estefania Morente Constatin, MDCINE RESIDENT, Pablo Romero Garcia, MDCINE RESIDENT, Margarita Gomez Morales, DOCTOR AND HEMATOLOGIST, Manuel Jurado, MD

Blood (2016) 128 (22): 5019.

https://doi.org/10.1182/blood.V128.22.5019.5019

Published: 2016

Journal Articles

Recombinant Factor IX in Surgical Management of Hemostasis in Hemophilia B Patients: A Prospective Clinical Trial

Jerzy Windyga, MD, Toshko Jelev Lissitchkov, MD, Vasily Mamonov, MD, Miranda Chapman, Srilatha D. Tangada, PhD, Brigitt E. Abbuehl, MD

Blood (2016) 128 (22): 2585.

https://doi.org/10.1182/blood.V128.22.2585.2585

Published: 2016

Journal Articles

Perioperative Management of Hemostasis with Recombinant FIX Fc Fusion Protein in Subjects Undergoing Surgery in the B-YOND Study

Margareth Castro Ozelo, MD PhD, Johnny Mahlangu, Godfrey Chan, Margareta Holmstrom, Nicolas Novitzky, David J Perry, Huixing Yuan, Lynda M Cristiano, Baisong Mei

Blood (2015) 126 (23): 1083.

https://doi.org/10.1182/blood.V126.23.1083.1083

Published: 2015

Journal Articles

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Brigitte Brand, Ralph A. Gruppo, MD, Tung T. Wynn, Laimonas Griskevicius, Maria Fernanda Lopez Fernandez, Thomas Dvorak, Lisa Patrone, Brigitt E. Abbuehl

Blood (2015) 126 (23): 2299.

https://doi.org/10.1182/blood.V126.23.2299.2299

Published: 2015

Journal Articles

Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A

Luigi Solimeno, MD, Steven R. Lentz, MD PhD, Irina Matytsina, MD, Niels Zeuthen, Faraizah Abdul Karim, MD, Elena Santagostino, MD PhD

Blood (2015) 126 (23): 2304.

https://doi.org/10.1182/blood.V126.23.2304.2304

Published: 2015

Journal Articles

Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study

Augusto Bramante Federici, MD, Giancarlo Castaman, MD, Alfonso Iorio, MD PhD, Emily Oliovecchio, Prodeswil Investigators

Blood (2015) 126 (23): 759.

https://doi.org/10.1182/blood.V126.23.759.759

Published: 2015

Journal Articles

Surgery in Von Willebrand Disease (VWD) Is Facilitated By a Novel 1:1 Plasma Derived Human Factor VWF/VIII Concentrate

Alok Srivastava, MD, Margit Serban, Prof. Dr., Sylvia Werner, Bruce A. Schwartz, PhD, Sigurd Knaub, PhD, Craig M. Kessler, MD

Blood (2014) 124 (21): 1504.

https://doi.org/10.1182/blood.V124.21.1504.1504

Published: 2014

Journal Articles

New Translocation (7:17) In Variant Acute Promyelocytic Leukemia With ATRA Resistance

Carolina Guillen, Lorena Mardones, Jorge Sánchez-Calero, Esther Jaro, Rocio Salgado, Juan Cigudosa, phD, Mercedes Carnero, Felix García-Sánchez, Begoña Fernández, Monteagudo María Dolores, María Jesús Gómez, María Angeles Andreu, Jacobina Cachá

Blood (2013) 122 (21): 4963.

https://doi.org/10.1182/blood.V122.21.4963.4963

Published: 2013

Journal Articles

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

John C. Chapin, MD, Jacqueline Bamme, MD, Fraustina Hsu, Paul Christos, Maria Teresa De Sancho, MD, MSc

Blood (2013) 122 (21): 1120.

https://doi.org/10.1182/blood.V122.21.1120.1120

Published: 2013

NARROW

Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center

Prospective Controlled Monitoring of Hemlibra Prophylaxis Initiation in a Large Cohort of Hemophilia a Patients- Real World Data

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study

Bleeding Risk Using INR/aPTT Pre-Surgery: Systemtic Review (BRUISR) (BRUISR)

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis

Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)

Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review

Bridging Therapy with Sodium Bemiparin at Therapeutic-Dose: Experience in Our Hospital

Recombinant Factor IX in Surgical Management of Hemostasis in Hemophilia B Patients: A Prospective Clinical Trial

Perioperative Management of Hemostasis with Recombinant FIX Fc Fusion Protein in Subjects Undergoing Surgery in the B-YOND Study

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A

Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study

Surgery in Von Willebrand Disease (VWD) Is Facilitated By a Novel 1:1 Plasma Derived Human Factor VWF/VIII Concentrate

New Translocation (7:17) In Variant Acute Promyelocytic Leukemia With ATRA Resistance

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only